JANX peer analysis
Janux (JANX) against its competitors: price, today's move, 1-year return and market value side by side.
JANX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CGEM Cullinan Therapeutics | $11.51 | 6.57% | 44.73% | – |
| CLDX Celldex Therapeutics | $30.00 | 6.12% | 18.41% | $2.35B |
| CMPX Compass Therapeutics | $0.77 | 12.99% | -81.63% | – |
| CTMX CytomX Therapeutics | $2.19 | 2.34% | -48.17% | $512.06M |
| IMNM Immunome | $19.48 | 8.80% | 16.19% | – |
| IMTX Immatics | $6.36 | 2.91% | -33.35% | – |
| LEGN Legend Biotech | $23.47 | 4.13% | -29.73% | $4.43B |
| MGNX MacroGenics | $2.33 | 4.95% | 54.14% | $147.15M |
| STRO Sutro Biopharma | $9.62 | 4.57% | -10.20% | $164.82M |
| VRXA Veraxa Biotech | $0.95 | 0.23% | – | – |
| JANX Janux | $17.63 | 9.78% | -40.61% | – |
- JANX's peers: CGEM (Cullinan Therapeutics), CLDX (Celldex Therapeutics), CMPX (Compass Therapeutics), CTMX (CytomX Therapeutics), IMNM (Immunome), IMTX (Immatics), LEGN (Legend Biotech), MGNX (MacroGenics).
Updated 2026-11-07 11:56 UTC